.

.

.

.

 

Latest APGI News

Pancreatic Cancer ACCENT Trial Reports Significant Patient Outcome

Pancreatic Cancer ACCENT Trial Reports Significant Patient Outcome

A significant development has emerged from the ACCENT pancreatic cancer clinical trial sponsored by Amplia Therapeutics in collaboration with Professor Paul Timpson and his team at the Garvan Institute of Medical Research, two patients have achieved a pathological...

Contact APGI

Australian Pancreatic Cancer Genome Initiative

The Kinghorn Cancer Centre

Garvan Institute of Medical Research

370 Victoria St, Darlinghurst

NSW 2010

Australia

On Twitter

Follow us on Twitter

Avner
APGI